Goldman Sachs upgraded Laboratory Corporation of America (NYSE: LH) from Sell to Neutral with a price target of $86.00 (from $79.00).
The firm cited: (1) a stable volume outlook, (2) strong FCF generation and balance sheet stability, (3) limited-to-zero exposure to ex-US macro uncertainty.
Notably, the price target still represents 7.1% downside.
Shares of Laboratory Corporation of America closed at $92.61 yesterday, with a 52 week range of $74.57-$99.76.
For the latest updates on the stock market, visit,
http://daytradingstock-blog.blogspot.com/